WEKO3
アイテム
{"_buckets": {"deposit": "08c918bd-4bbb-4d5a-a639-497d8a0c1449"}, "_deposit": {"created_by": 18, "id": "13110", "owners": [18], "pid": {"revision_id": 0, "type": "depid", "value": "13110"}, "status": "published"}, "_oai": {"id": "oai:ir.kagoshima-u.ac.jp:00013110", "sets": ["78"]}, "author_link": ["117763", "117764", "117765", "117766", "117767", "117768", "117769", "117770", "117771", "117772", "117773"], "item_6_biblio_info_5": {"attribute_name": "収録雑誌名", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2011", "bibliographicIssueDateType": "Issued"}, "bibliographicPageStart": "454", "bibliographicVolumeNumber": "11", "bibliographic_titles": [{"bibliographic_title": "BMC Cancer", "bibliographic_titleLang": "en"}]}]}, "item_6_date_6": {"attribute_name": "作成日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2011-10-20", "subitem_date_issued_type": "Issued"}]}, "item_6_description_4": {"attribute_name": "要約(Abstract)", "attribute_value_mlt": [{"subitem_description": "Background: Human leukocyte antigen (HLA)-class I molecules on tumor cells have been regarded as crucial sites where cytotoxic T lymphocytes (CTL) can recognize tumor-specific antigens and are strongly associated with antitumor activity. However, the clinical impact of HLA class I expression in breast cancer has not been clarified.\nMethods: A total of 212 breast cancer patients who received curative surgery from 1993 to 2003 were enrolled in the current study. HLA class I expression was examined immunohistochemically using an anti-HLA class I monoclonal antibody. The correlation between HLA class I positivity and clinical factors was analyzed.\nResults: The downregulation of HLA class I expression in breast cancer was observed in 69 patients (32.5%). HLA class I downregulation was significantly associated with nodal involvement (p \u003c 0.05), TNM stage (p \u003c 0.05), lymphatic invasion (p \u003c 0.01), and venous invasion (p \u003c 0.05). Patients with preserved HLA class I had significantly better disease-free interval (DFI) than those with loss of HLA class I (p \u003c 0.05). However, in multivariable analysis, HLA class I was not selected as one of the independent prognostic factors of disease-free interval.\nConclusion: The examination of HLA class I expression is useful for the prediction of tumor progression and recurrent risk of breast cancer via the antitumor immune system.", "subitem_description_language": "en", "subitem_description_type": "Other"}]}, "item_6_publisher_23": {"attribute_name": "公開者・出版者", "attribute_value_mlt": [{"subitem_publisher": "BioMed Central", "subitem_publisher_language": "en"}]}, "item_6_relation_11": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1186/1471-2407-11-454", "subitem_relation_type_select": "DOI"}}]}, "item_6_rights_12": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "(C) 2011 Kaneko et al; licensee BioMed Central Ltd.", "subitem_rights_language": "en"}]}, "item_6_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "14712407", "subitem_source_identifier_type": "EISSN"}]}, "item_6_subject_15": {"attribute_name": "NDC", "attribute_value_mlt": [{"subitem_subject": "495", "subitem_subject_scheme": "NDC"}]}, "item_6_text_30": {"attribute_name": "NIIタイプ", "attribute_value_mlt": [{"subitem_text_value": "Journal Article"}]}, "item_6_version_type_14": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kaneko, Koichi", "creatorNameLang": "en"}, {"creatorName": "カネコ, コウイチ", "creatorNameLang": "ja-Kana"}, {"creatorName": "金子, 公一", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117763", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ishigami, Sumiya", "creatorNameLang": "en"}, {"creatorName": "イシガミ, スミヤ", "creatorNameLang": "ja-Kana"}, {"creatorName": "石神, 純也", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117764", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kijima, Yuko", "creatorNameLang": "en"}, {"creatorName": "キジマ, ユウコ", "creatorNameLang": "ja-Kana"}, {"creatorName": "喜島, 祐子", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117765", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Funasako, Yawara", "creatorNameLang": "en"}, {"creatorName": "フナサコ, ヤワラ", "creatorNameLang": "ja-Kana"}, {"creatorName": "舩迫, 和", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117766", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hirata, Munetsugu", "creatorNameLang": "en"}, {"creatorName": "ヒラタ, ムネツグ", "creatorNameLang": "ja-Kana"}, {"creatorName": "平田, 宗嗣", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117767", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okumura, Hiroshi", "creatorNameLang": "en"}, {"creatorName": "オクムラ, ヒロシ", "creatorNameLang": "ja-Kana"}, {"creatorName": "奥村, 浩", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117768", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shinchi, Hiroyuki", "creatorNameLang": "en"}, {"creatorName": "シンチ, ヒロユキ", "creatorNameLang": "ja-Kana"}, {"creatorName": "新地, 洋之", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117769", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Koriyama, Chihaya", "creatorNameLang": "en"}, {"creatorName": "コオリヤマ, チハヤ", "creatorNameLang": "ja-Kana"}, {"creatorName": "郡山, 千早", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117770", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ueno, Shinichi", "creatorNameLang": "en"}, {"creatorName": "ウエノ, シンイチ", "creatorNameLang": "ja-Kana"}, {"creatorName": "上野, 真一", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117771", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yoshinaka, Heiji", "creatorNameLang": "en"}, {"creatorName": "ヨシナカ, ヘイジ", "creatorNameLang": "ja-Kana"}, {"creatorName": "吉中, 平次", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117772", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Natsugoe, Shoji", "creatorNameLang": "en"}, {"creatorName": "ナツゴエ, ショウジ", "creatorNameLang": "ja-Kana"}, {"creatorName": "夏越, 祥次", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "117773", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2016-10-31"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "Clinical implication of HLA class I expression in breast cancer.pdf", "filesize": [{"value": "953.6 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 953600.0, "url": {"label": "Clinical implication of HLA class I expression in breast cancer.pdf", "objectType": "fulltext", "url": "https://ir.kagoshima-u.ac.jp/record/13110/files/Clinical implication of HLA class I expression in breast cancer.pdf"}, "version_id": "8a80d5e0-2b37-4b84-a0ae-c51c2d9cfb34"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "HLA class I", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "survival", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "T cell immunology", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "antitumor activity", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Clinical implication of HLA class I expression in breast cancer", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Clinical implication of HLA class I expression in breast cancer", "subitem_title_language": "en"}]}, "item_type_id": "6", "owner": "18", "path": ["78"], "permalink_uri": "http://hdl.handle.net/10232/20319", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2014-01-30"}, "publish_date": "2014-01-30", "publish_status": "0", "recid": "13110", "relation": {}, "relation_version_is_last": true, "title": ["Clinical implication of HLA class I expression in breast cancer"], "weko_shared_id": -1}
Clinical implication of HLA class I expression in breast cancer
http://hdl.handle.net/10232/20319
http://hdl.handle.net/10232/20319580f1edc-dd8d-405c-8a7d-8c5393edda07
名前 / ファイル | ライセンス | アクション |
---|---|---|
Clinical implication of HLA class I expression in breast cancer.pdf (953.6 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2014-01-30 | |||||
タイトル | ||||||
タイトル言語 | en | |||||
タイトル | Clinical implication of HLA class I expression in breast cancer | |||||
著者 |
金子, 公一
× 金子, 公一× 石神, 純也× 喜島, 祐子× 舩迫, 和× 平田, 宗嗣× 奥村, 浩× 新地, 洋之× 郡山, 千早× 上野, 真一× 吉中, 平次× 夏越, 祥次 |
|||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題言語 | en | |||||
主題Scheme | Other | |||||
主題 | HLA class I | |||||
キーワード | ||||||
主題言語 | en | |||||
主題Scheme | Other | |||||
主題 | survival | |||||
キーワード | ||||||
主題言語 | en | |||||
主題Scheme | Other | |||||
主題 | T cell immunology | |||||
キーワード | ||||||
主題言語 | en | |||||
主題Scheme | Other | |||||
主題 | antitumor activity | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
要約(Abstract) | ||||||
内容記述タイプ | Other | |||||
内容記述 | Background: Human leukocyte antigen (HLA)-class I molecules on tumor cells have been regarded as crucial sites where cytotoxic T lymphocytes (CTL) can recognize tumor-specific antigens and are strongly associated with antitumor activity. However, the clinical impact of HLA class I expression in breast cancer has not been clarified. Methods: A total of 212 breast cancer patients who received curative surgery from 1993 to 2003 were enrolled in the current study. HLA class I expression was examined immunohistochemically using an anti-HLA class I monoclonal antibody. The correlation between HLA class I positivity and clinical factors was analyzed. Results: The downregulation of HLA class I expression in breast cancer was observed in 69 patients (32.5%). HLA class I downregulation was significantly associated with nodal involvement (p < 0.05), TNM stage (p < 0.05), lymphatic invasion (p < 0.01), and venous invasion (p < 0.05). Patients with preserved HLA class I had significantly better disease-free interval (DFI) than those with loss of HLA class I (p < 0.05). However, in multivariable analysis, HLA class I was not selected as one of the independent prognostic factors of disease-free interval. Conclusion: The examination of HLA class I expression is useful for the prediction of tumor progression and recurrent risk of breast cancer via the antitumor immune system. |
|||||
内容記述言語 | en | |||||
収録雑誌名 |
en : BMC Cancer 巻 11, p. 454, 発行日 2011 |
|||||
作成日 | ||||||
日付 | 2011-10-20 | |||||
日付タイプ | Issued | |||||
ISSN | ||||||
収録物識別子タイプ | EISSN | |||||
ISSN | 14712407 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
DOI | https://doi.org/10.1186/1471-2407-11-454 | |||||
権利 | ||||||
権利情報の言語 | en | |||||
権利情報 | (C) 2011 Kaneko et al; licensee BioMed Central Ltd. | |||||
出版タイプ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
NDC | ||||||
主題Scheme | NDC | |||||
主題 | 495 | |||||
公開者・出版者 | ||||||
出版者言語 | en | |||||
出版者 | BioMed Central |